Search
for
Sort by
Research 271–300 of 522
- The Involvement of RIPK1 in Alopecia Areata
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Autoinmune Alopecia/Alopecia Areata
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Drug Armamentarium for alopecia areata
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Recent Advances in Drug Development for Hair Loss
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- An Updated in the Management of Alopecia Areata
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- 1432 IL-9/IL-9R signaling as a novel regulator of human hair follicle growth and immune privilege
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment